Business Features

Annual Report Contents > Business Features

CSL's business activities include CSL Behring, CSL Bioplasma, CSL Biotherapies and our global research and development operations.

CSL Behring Feature
CSL Bioplasma Feature
CSL Biotherapies Feature
New Product Development Feature

See also Business Reports

Back | Next

In Melbourne, construction of new influenza vaccine production facilities is on track to deliver CSL additional capacity in 2008. Checking progress in the ultrafiltration plant are Andrew Bervanakis, (Senior Project Manager, CSL Biotherapies), Mary Sontrop, (General Manager, CSL Biotherapies, Australia and New Zealand), and Cameron Barrett, (CSL's Director, IT and Facilities)..